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A post-column derivatization HPLC method with visible absorbance detection at 521 nm was modified
for the simultaneous determination of Fe(II) and Fe(III) in mixtures. The method was applied to
pharmaceuticals marketed in Turkey. Iron species were separated on a post-column derivatization HPLC,
IonPac CS5A (4x250 mm) analytical column using a pyridine-2,6-dicarboxylic acid based eluent. The
determinations of Fe(II) and Fe(III) were also realized by the most common method of FAAS, total
iron determination. Detection limits (3S) were found to be 0.109 µg/L for Fe(II) and 0.217 µg/L for
Fe(III), respectively. The mean recovery of the HPLC and AAS method was found to be 98-101%. This
application note, by using the principles of ion exchange, describes an attractive alternative to traditional
spectroscopic methods.
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Introduction
Metal ions can exist in several forms. Ion-exchange plays an important role in modern analytical chemistry.
Transition metals can be separated using either anion or cation exchange chromatography, depending on the
choice of complexing agent used in the eluent1 .
Iron deficiency is the most common of nutritional anemia in human beings. It is also an essential
component of myoglobin, cytochomes, catalase and peroxidase. Iron deficiency can affect the metabolism in
muscle independently of the effect of anemia on oxygen delivery. Its deficiency has also been associated with
behavioral and learning problems in children and with abnormalities in the catecholamine metabolism2. Iron
preparations are one of the most commonly used medicaments for the problems arising due to iron deficiency
in human beings.
An adult male has a requirement of only 13 µg/kg per day (about 1 mg) whereas a menstruating female
requires about 21 µg/ kg per day (about 1.4 mg). In the last two trimesters of pregnancy, requirements
∗ Corresponding
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increase to about 80 µg/kg per day (5-6 mg) and the infant has similar requirements due to its rapid growth.
The usual therapeutic dose of iron is about 200 mg per day (2-3 mg/kg). Children weighing 15 to 30 kg
can take half the average adult dose and small children and infants can tolerate relatively larger doses (5
mg/kg)3 .
Methods used for the assay of iron in various samples include ion chromatography4−6 , UV-Vis.
spectrophotometry7−9 and atomic absorption spectrometry10 .
In this study, a simple, rapid and specific HPLC method for the determination of Fe(II) and Fe(III)
is developed. The method is also selective enough for the simultaneous determination of Fe(II) and Fe(III)
in various matrices. Most of the Fe preparations on the market are in the form of Fe(II). The ones in the
form of Fe(III) are reduced to Fe(II) within the human organism. In order to obtain maximum efficiency in
terms of bioavailability, the iron given to the metabolism should be in the form of Fe(II)11,12 . Since Fe(II)
can easily be oxidized to Fe(III) by the effect of air and light, the simultaneous determination of the Fe(II)
and Fe(III) contents of the preparations becomes very important.

Experimental
Instrumention
An HP (Agilent) 1100 High Performance Liquid Chromatograph was coupled with a Dionex PC10 PostColumn Delivery (PCD) System. Fe(II) and Fe(III) were detected with an HP Variable Wavelength UV-Vis
detector at 521 nm.
The IonPac CS5A analytical column (4x250 mm, sulfonic acid alkanol quaternary ammonium) and
CG5A guard (4x50mm) column were used for the separation process.

The nature of the cross-linked

polymeric structure of the packing materials makes the CS5A column compatible with pH 0-14 eluents.
An ATI-UNICAM 929 Atomic Absorption Spectrometer was also used for the determination of total Fe.
A schematic diagram of the HPLC/PCD system is given in Figure 1 and the operating conditions of
the system are listed in Table 1.
in from Hp 1100 pump
IonPac C85A column

Mixing Tea

PAR Reservoir

Post-Column
Reagent (PAR)
Control Valve

Kinitted
Reaction
Coil

HP 1100 UV Detector

Figure 1. A schematic diagram of the HPLC/PCD system for iron separation.

Chemicals
Fe(III) ion standard for AAS of 1000±0.5% mg/L in 1 M HNO3 was provided from Fisher Scientific.
FeSO4 .7H2 O was from Merck Chemicals. PDCA (pyridine-2,6-dicarboxylic acid), KOH, HCOOH, K2 SO4 ,
PAR (4-(2-pyridylazo)resorcinol), and Postcolumn Reagent Diluent were from Dionex Co. Standard solutions
were prepared from stock solutions just prior to use. Iron drugs were obdained from the market in Turkey.
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Table 1. Operating conditions of the system.

HPLC / Post-Column Delivery System
Columns: Ionpac CS5A Analytical and CG5A Guard Column.
Eluent: 7.0 mM pyridine-2-6-dicarboxylic acid/66 mM potasium hydroxide/5.6 mM potasium sulfate/74 mM formic acid in 1 L de-ionized water.
(final pH: 4.2 ± 0.1)
Eluent Flow Rate: 1.2 mL/min.
Injection Volume: 100 µL.
Detector: HP 1100 VW UV-Vis Detector at 521nm.
Post-column Reagent: 0.5 mM 4-(2-pyridylazo)resorcinol (PAR) in Postcolumn Reagent
Diluent.
Post-column Reagent Flow Rate: 0.6 mL/min.
Post-column Reagent Diluent 1.0 M 2-dimethylaminoethanol/0.50M aqueous ammonia/0.30M sodium bicarbonate pH: 10.4 ± 0.2.
Reaction Coil: 375µL Knitted Reaction Coil.

Chemicals
Fe(III) ion standard for AAS of 1000±0.5% mg/L in 1 M HNO3 was provided from Fisher Scientific.
FeSO4 .7H2 O was from Merck Chemicals. PDCA (pyridine-2,6-dicarboxylic acid), KOH, HCOOH, K2 SO4 ,
PAR (4-(2-pyridylazo)resorcinol), and Postcolumn Reagent Diluent were from Dionex Co. Standard solutions
were prepared from stock solutions just prior to use. Iron drugs were obtained from the market in Turkey.
Iron solutions: 100mg/L Fe(II) stock solution was prepared by dissolving 0.050 g FeSO4 .7H2 O (Merck)
in 100mL de-ionized water. Then 1.50 mL was diluted to 100mL with de-ionized water to give 1.50 mg/L
Fe(II) standard; 150µL Fe(III) AAS standard was diluted to 100mL with de-ionized water to give 1.50mg/L
Fe(III) standard.
De-ionized water was obtained via the MILLIPORE water system (Elix-10 followed by Milli-Q 185
Plus) and a 0.22 µm filter unit.

Methods
HPLC Procedure
Applying the AAS method, Fe(II) and Fe(III) can not be determined separately, but the total Fe content of
the sample can be determined13,14 . However, by using the proposed method, separate peaks were obtained
for Fe(II) and Fe(III) on chromatogram. A chromatogram obtained from Fe(II) (prepared from FeSO4 ) and
Fe(III) (prepared from standard of AAS) standards is shown in Figure 2. The observed retention times were
5.2 min and 11.6 min for Fe(II) and Fe(III), respectively.
For this purpose, prior to application to the pharmaceutical samples, quantification was performed
with synthetic samples of 1.5 ppm Fe(II) as FeSO4 and 1.5 ppm Fe(III) as Fe3+ AAS standard, separately and
together. Appropriate results were obtained and it was decided to apply the method to the pharmaceutical
samples.
In this way, any sample containing Fe(II) and Fe(III) can simultaneously be determined. For the
application of the method, 10 iron tablets were weighed, and finely powdered and an equivalent weight of a
tablet was transferred into a 1L volumetric flask containing about 900 mL of water, and it was ultrasonicated
for 30 min and diluted to 1L with water. The solution was filtered through a 0.45 µm nylon filter. From this
427
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stock solution 1.5 ppm equivalent of iron solution was prepared. This solution was filtered before injection
to HPLC.

Figure 2. A typical HPLC chromatogram of Fe(II) and Fe(III) standards using the proposed method for separation.

Then 100 mM Na2 SO3 was passed through the column for 1 h at 1.0 mL/min to eliminate any oxygen
build-up on the column at the beginning of the experiment. Eluent was pumped with a flow rate of 1.2
mL/min until a stable baseline was achieved. Post-column reagent was pumped with a flow rate of 0.6
mL/min towards the mixing tee as shown in Fig. 1. A 100µL sample or standard was injected into the
system. The separation of Fe(II) and Fe(III) were realized and the components reached the mixing tee.
They both reacted with the post-column derivatization reagent in the knitted reaction coil to give a colored
complex and were determined with a UV-Vis detector at 521 nm.
AAS Procedure
Pharmaceutical samples were digested via a MILESTONE MDR-1200 Microwave Furnace using concentrated
HNO3 :H2 O2 (5mL:1mL) mixture and diluted to 25 mL with deionized water.
An ATI-UNICAM Atomic Absorption Spectrophotometer equipped with a D2 arc background correction system was used for total Fe determination at 248.3 nm, with a 12.0 mA Fe hollow cathode lamp
and air/acetylene flame13,14.

Results and Discussion
Standard Curve
Calibration standards were prepared using concentrations of 0.05, 0.2, 0.5, 1.25 and 2.5 mg/L of Fe(II) and
Fe(III) in deionized water. These standards were prepared daily from the stock solution. The calibration
graphs obtained for Fe(II) and Fe(III) including best fit equations are shown in Figure 3.
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Figure 3. Calibration graphs for Fe(II) and Fe(III)
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3.2. Limit of Quantitation and Limit of Detection
The limit of quantitation was determined from the iron peaks and the standard deviation of the S/N ratio.
The limit of quantitation was defined as the iron concentration resulting in a height of 10 times S/N and
was calculated as 0.363 µg/L and 0.723 µg/L for Fe(II) and Fe(III), respectively.
The limit of detection was defined as the concentration of iron species that produces an analytical
signal equal to thrice the standard deviation of the background signal15 and was calculated as 0.109 µg/L
for Fe(II) and 0.217 µg/L for Fe(III).
The results obtained using the proposed method for the determination of Fe(II) and Fe(III) by HPLC
and total Fe content by AAS in 7 different pharmaceuticals marketed in Turkey are shown in Table 2.
It is well known that speciation analysis plays a unique role in the testing of some products. A
chromatographic method was developed for the simultaneous determination of Fe(II) and Fe(III). The
proposed method is reproducible, rapid and simple to use in assaying pharmaceuticals for Fe(II) and Fe(III)
determinations. The detection limits for Fe(II) and Fe(III) were 0.109 µg/L for Fe(II) and 0.217 µg/L for
Fe(III) by using the post-column-derivativatization/HPLC technique at 521 nm. The results indicate that
values obtained both from HPLC and AAS were in good agreement with the values of pharmaceuticals. The
mean recovery of both methods was found to be 98 -101%.
Table 2. The results of iron determination in pharmaceuticals.

Declared
Amount
(mg)
Synthetic
Fe (II)
Synthetic
Fe(III)
Synthetic
Mixture
(Fe2+ and Fe
UA
TB
FC
SD
LE
FG
FH
∗

3+

A A S*
Found
(mg)
Fe %

H P L C*
Found
(mg)

Fe(II) %

Fe(III) %

80.50

79.54±0.03

98.81

80.86±0.03

100.44

-

100.10

100.72±0.04

100.62

98.77±0.06

-

98.67

80.50 Fe2+
100.10 Fe3+

79.68±0.04
100.28±0.04

98.98
100.18

80.71±0.05
99.96±0.07

100.26

99.86

10.00 Fe2+
80.00 Fe2+
100.00 Fe3+
10.00 Fe2+
80.50 Fe2+
100.00 Fe2+
100.00 Fe3+

10.10±0.04
79.86±0.03
100.77±0.06
10.12±0.07
80.66±0.08
100.28±0.02
98.00±0.06

101.00
99.83
100.77
101.20
100.02
100.28
98.00

10.03±0.09
80.30±0.06
100.30±0.02
10.03±0.02
80.74±0.07
102.00±0.06
99.80±0.07

100.30
100.37
100.30
100.30
102.00
8.80

100.30
91.00

)

Results are given as X ±

ts
√
N

(N=4)

As can be seen from Table 2, the Fe content of a medicament containing 100 mg of Fe(III) was found
to be 91% Fe(III) and 8.8% Fe(II). If a sample has both ionic form together, this method is suitable for the
simultaneous determination of Fe(II) and Fe(III).
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